With $19.5 million in new financing fuel, Boulder, Colo.-based SomaLogic is readying to launch its price-busting aptamer protein microarrays by the fourth quarter this year, according to David Brunel, the company’s CEO.
The financing, a series C round closed Feb. 20, will be used mostly for R&D on the aptamer arrays, the company said.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.